Efficacy and tolerability of immunotherapy in advanced nasopharyngeal carcinoma with or without chemotherapy: a meta-analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Brazilian journal of otorhinolaryngology"
DOI: 10.1016/j.bjorl.2021.04.002
Abstract: INTRODUCTION Evidence of programmed death-1 inhibitors in nasopharyngeal carcinoma has been accumulated. However, previous clinical studies were basically small sample size. OBJECTIVE This study aimed to summarize existing studies to comprehensively compare programmed death-1 inhibitors… read more here.
Keywords: programmed death; nasopharyngeal carcinoma; death; without chemotherapy ... See more keywords
Nivolumab with or without chemotherapy for metastatic gastroesophageal cancers and future perspectives
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2022.2139241
Abstract: ABSTRACT Introduction Gastroesophageal cancers (GEC) are frequently found at the advanced stage. GEC treatment advancements have been limited and prognosis, therefore, remains poor. Through numerous clinical trials, the addition of immune checkpoint inhibitors, including nivolumab,… read more here.
Keywords: nivolumab without; gastroesophageal; chemotherapy metastatic; gastroesophageal cancers ... See more keywords
Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancer
Sign Up to like & getrecommendations! Published in 2020 at "Scandinavian Journal of Urology"
DOI: 10.1080/21681805.2019.1711160
Abstract: Abstract Objectives: To evaluate cancer-specific (CSS) and overall survival (OS) in a group of frail patients who were treated with RT without chemotherapy and to compare them with a matched cohort of patients treated with… read more here.
Keywords: chemotherapy; bladder cancer; patients treated; frail patients ... See more keywords
Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1044098
Abstract: Introduction Few data about the safety of immune checkpoint inhibitors (ICIs) in the patients with solid tumor with Occult Hepatitis B Virus (OBI) are available. According to the Taormina Workshop on Occult HBV Infection Faculty… read more here.
Keywords: immunotherapy; hepatitis; occult hepatitis; study ... See more keywords